This is a draft item of legislation. This draft has since been made as a UK Statutory Instrument: The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022 No. 350
3.Amendment to regulation 3A (preparation and assembly of medicinal products used for vaccination or immunisation against coronavirus or in the reformulation of such products)
4.Amendment to regulation 19 (exemptions from requirement for wholesale dealer’s licence)
5.Amendment to regulation 229 (exemption for supply by national health service bodies and local authorities)
6.Amendment to regulation 233 (exemption for supply etc under a PGD by person conducting a retail pharmacy business)
7.Amendment to regulation 235 (exemption for sale, supply or administration by certain persons)
The data on this page is available in the alternative data formats listed:
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
